Quốc gia: Hoa Kỳ
Ngôn ngữ: Tiếng Anh
Nguồn: NLM (National Library of Medicine)
MORPHINE SULFATE (UNII: X3P646A2J0) (MORPHINE - UNII:76I7G6D29C)
STAT Rx USA LLC
MORPHINE SULFATE
MORPHINE SULFATE 15 mg
ORAL
PRESCRIPTION DRUG
Morphine Sulfate Extended-Release Tablets are an extended-release oral formulation of morphine sulfate indicated for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. Morphine Sulfate Extended-Release Tablets are NOT intended for use as a prn analgesic. The Morphine Sulfate Extended-Release Tablets 100 and 200 mg tablet strengths are high dose, extended-release, oral morphine formulations indicated for the relief of pain in opioid-tolerant patients only. Morphine Sulfate Extended-Release Tablets are not indicated for pain in the immediate postoperative period (the first 12-24 hours following surgery) for patients not previously taking the drug, because its safety in this setting has not been established. Morphine Sulfate Extended-Release Tablets are not indicated for pain in the postoperative period if the pain is mild, or not expected to persist for an extended period of time. Morphine Sulfate Extended-Release Tablets are
Morphine Sulfate Extended-Release Tablets 15 mg are round, blue-colored, film-coated tablets bearing the symbol ABG on one side and 15 on the other. They are supplied as follows: Bottles of 30 - NDC 16590-966-30 Bottles of 60 - NDC 16590-966-60 Bottles of 90 - NDC 16590-966-90 Dispense in a tight, light-resistant container. Healthcare professionals can telephone Rhodes Pharmaceuticals at 1-888-827-0616 for information on this product. CAUTION DEA Order Form Required. Distributed By: Rhodes Pharmaceuticals L.P. Coventry, RI 02816 Manufactured By: Purdue Pharmaceuticals L.P. Wilson, NC 27893 Component No: 302567-0A Rev. 08/10 Relabeling and Repackaging by: STAT Rx USA LLC Gainesville, GA 30501
Abbreviated New Drug Application
MORPHINE SULFATE - MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE STAT RX USA LLC ---------- MORPHINE SULFATE ER - C-II 15 MG TABLETS WARNING: MORPHINE SULFATE EXTENDED-RELEASE TABLETS CONTAIN MORPHINE SULFATE, AN OPIOID AGONIST AND A SCHEDULE II CONTROLLED SUBSTANCE, WITH AN ABUSE LIABILITY SIMILAR TO OTHER OPIOID ANALGES ICS . MORPHINE CAN BE ABUSED IN A MANNER SIMILAR TO OTHER OPIOID AGONISTS, LEGAL OR ILLICIT. THIS SHOULD BE CONSIDERED WHEN PRESCRIBING OR DISPENSING MORPHINE SULFATE EXTENDED-RELEASE TABLETS IN SITUATIONS WHERE THE PHYSICIAN OR PHARMACIST IS CONCERNED ABOUT AN INCREASED RISK OF MISUSE, ABUSE, OR DIVERSION. MORPHINE SULFATE EXTENDED-RELEASE TABLETS ARE AN EXTENDED-RELEASE ORAL FORMULATION OF MORPHINE SULFATE INDICATED FOR THE MANAGEMENT OF MODERATE TO SEVERE PAIN WHEN A CONTINUOUS, AROUND-THE-CLOCK OPIOID ANALGESIC IS NEEDED FOR AN EXTENDED PERIOD OF TIME. MORPHINE SULFATE EXTENDED-RELEASE TABLETS ARE NOT INTENDED FOR USE AS A PRN ANALGESIC. MORPHINE SULFATE EXTENDED-RELEASE 100 AND 200 MG TABLETS ARE FOR USE IN OPIOID- TOLERANT PATIENTS ONLY. THESE TABLET STRENGTHS MAY CAUSE FATAL RESPIRATORY DEPRESSION WHEN ADMINISTERED TO PATIENTS NOT PREVIOUSLY EXPOSED TO OPIOIDS. MORPHINE SULFATE EXTENDED-RELEASE TABLETS ARE TO BE SWALLOWED WHOLE AND ARE NOT TO BE BROKEN, CHEWED, DISSOLVED, OR CRUSHED. TAKING BROKEN, CHEWED, DISSOLVED, OR CRUSHED MORPHINE SULFATE EXTENDED-RELEASE TABLETS LEADS TO RAPID RELEASE AND ABSORPTION OF A POTENTIALLY FATAL DOSE OF MORPHINE. DESCRIPTION Chemically, morphine sulfate is 7,8-didehydro-4,5α-epoxy-17-methylmorphinan-3,6α-diol sulfate (2:1) (salt) pentahydrate and has the following structural formula: Morphine Sulfate Extended-Release Tablets are opiate analgesics supplied in 15, 30, 60, 100 and 200 mg tablet strengths. The tablet strengths describe the amount of morphine per tablet as the pentahydrated sulfate salt (morphine sulfate, USP). Morphine Sulfate Extended-Release Tablets 15 mg, 30 mg, 60 mg, 100 mg, and 200 mg contain the following inactive ingredient Đọc toàn bộ tài liệu